Literature DB >> 23811579

Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.

Viraj Kulkarni1, Margherita Rosati2, Jenifer Bear1, Guy R Pilkington1, Rashmi Jalah1, Cristina Bergamaschi1, Ashish K Singh2, Candido Alicea1, Bhabadeb Chowdhury2, Gen-Mu Zhang3, Eun-Young Kim4, Steven M Wolinsky4, Wensheng Huang5, Yongjun Guan5, Celia LaBranche6, David C Montefiori6, Kate E Broderick7, Niranjan Y Sardesai7, Antonio Valentin2, Barbara K Felber1, George N Pavlakis2.   

Abstract

A panel of SIVmac251 transmitted Env sequences were tested for expression, function and immunogenicity in mice and macaques. The immunogenicity of a DNA vaccine cocktail expressing SIVmac239 and three transmitted SIVmac251 Env sequences was evaluated upon intradermal or intramuscular injection followed by in vivo electroporation in macaques using sequential vaccination of gp160, gp120 and gp140 expressing DNAs. Both intradermal and intramuscular vaccination regimens using the gp160 expression plasmids induced robust humoral immune responses, which further improved using the gp120 expressing DNAs. The responses showed durability of binding and neutralizing antibody titers and high avidity for>1 y. The intradermal DNA delivery regimen induced higher cross-reactive responses able to neutralize the heterologous tier 1B-like SIVsmE660_CG7V. Analysis of cellular immune responses showed induction of Env-specific memory responses and cytotoxic granzyme B(+) T cells in both vaccine groups, although the magnitude of the responses were ~10x higher in the intramuscular/electroporation group. The cellular responses induced by both regimens were long lasting and could be detected ~1 y after the last vaccination. These data show that both DNA delivery methods are able to induce robust and durable immune responses in macaques.

Entities:  

Keywords:  DNA vaccine; HIV; SIVmac239; SIVmac251; SIVsmE660; avidity; binding antibody; effector memory; in vivo electroporation; intradermal; intramuscular; neutralizing antibody; transitional memory; transmitted Env

Mesh:

Substances:

Year:  2013        PMID: 23811579      PMCID: PMC3906392          DOI: 10.4161/hv.25473

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  64 in total

1.  A novel electroporation device for gene delivery in large animals and humans.

Authors:  Torunn Elisabeth Tjelle; Ragnar Salte; Iacob Mathiesen; Rune Kjeken
Journal:  Vaccine       Date:  2005-09-01       Impact factor: 3.641

2.  DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.

Authors:  Margherita Rosati; Agneta von Gegerfelt; Patricia Roth; Candido Alicea; Antonio Valentin; Marjorie Robert-Guroff; David Venzon; David C Montefiori; Phil Markham; Barbara K Felber; George N Pavlakis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.

Authors:  D H Fuller; L Simpson; K S Cole; J E Clements; D L Panicali; R C Montelaro; M Murphey-Corb; J R Haynes
Journal:  Immunol Cell Biol       Date:  1997-08       Impact factor: 5.126

Review 4.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.

Authors:  Angela M Bodles-Brakhop; Richard Heller; Ruxandra Draghia-Akli
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

5.  Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation.

Authors:  G Rizzuto; M Cappelletti; D Maione; R Savino; D Lazzaro; P Costa; I Mathiesen; R Cortese; G Ciliberto; R Laufer; N La Monica; E Fattori
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.

Authors:  Feng Lin; Xuefei Shen; Jay R McCoy; Janess M Mendoza; Jian Yan; Steve V Kemmerrer; Amir S Khan; David B Weiner; Kate E Broderick; Niranjan Y Sardesai
Journal:  Vaccine       Date:  2011-01-01       Impact factor: 3.641

7.  Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Authors:  Sampa Santra; Hua-Xin Liao; Ruijin Zhang; Mark Muldoon; Sydeaka Watson; Will Fischer; James Theiler; James Szinger; Harikrishnan Balachandran; Adam Buzby; David Quinn; Robert J Parks; Chun-Yen Tsao; Angela Carville; Keith G Mansfield; George N Pavlakis; Barbara K Felber; Barton F Haynes; Bette T Korber; Norman L Letvin
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

8.  Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays.

Authors:  David C Montefiori
Journal:  Curr Protoc Immunol       Date:  2005-01

9.  Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.

Authors:  Feng Lin; Xuefei Shen; Gleb Kichaev; Janess M Mendoza; Maria Yang; Philip Armendi; Jian Yan; Gary P Kobinger; Alexander Bello; Amir S Khan; Kate E Broderick; Niranjan Y Sardesai
Journal:  Hum Gene Ther Methods       Date:  2012-07-13       Impact factor: 2.396

10.  Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge.

Authors:  Lauren A Hirao; David A Hokey; Matthew P Morrow; Maria N Jure-Kunkel; David B Weiner
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

View more
  19 in total

1.  Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes.

Authors:  Jamie F S Mann; Paul F McKay; Anezka Fiserova; Katja Klein; Alethea Cope; Paul Rogers; Julie Swales; Michael S Seaman; Behazine Combadiere; Robin J Shattock
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

2.  Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.

Authors:  Diego A Vargas-Inchaustegui; Iskra Tuero; Venkatramanan Mohanram; Thomas Musich; Poonam Pegu; Antonio Valentin; Yongjun Sui; Margherita Rosati; Jenifer Bear; David J Venzon; Viraj Kulkarni; Candido Alicea; Guy R Pilkington; Namal P M Liyanage; Thorsten Demberg; Shari N Gordon; Yichuan Wang; Alison E Hogg; Blake Frey; L Jean Patterson; Janet DiPasquale; David C Montefiori; Niranjan Y Sardesai; Steven G Reed; Jay A Berzofsky; Genoveffa Franchini; Barbara K Felber; George N Pavlakis; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2014-06-04       Impact factor: 3.969

3.  Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.

Authors:  Viraj Kulkarni; Margherita Rosati; Antonio Valentin; Rashmi Jalah; Candido Alicea; Lei Yu; Yongjun Guan; Xiaoying Shen; Georgia D Tomaras; Celia LaBranche; David C Montefiori; Carmela Irene; Rajasekhar Prattipati; Abraham Pinter; Sean M Sullivan; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2013-07-02       Impact factor: 3.452

4.  A novel real-time CTL assay to measure designer T-cell function against HIV Env(+) cells.

Authors:  Andrew G MacLean; Edith Walker; Gautam K Sahu; Gail Skowron; Preston Marx; Dorothee von Laer; Richard P Junghans; Stephen E Braun
Journal:  J Med Primatol       Date:  2014-08-20       Impact factor: 0.667

Review 5.  DNA vaccines, electroporation and their applications in cancer treatment.

Authors:  Si-Hyeong Lee; Sayyed Nilofar Danishmalik; Jeong-Im Sin
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.

Authors:  Charlotta Nilsson; Bo Hejdeman; Karina Godoy-Ramirez; Teghesti Tecleab; Gabriella Scarlatti; Andreas Bråve; Patricia L Earl; Richard R Stout; Merlin L Robb; Robin J Shattock; Gunnel Biberfeld; Eric Sandström; Britta Wahren
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

7.  Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques.

Authors:  Antonio Valentin; Jinyao Li; Margherita Rosati; Viraj Kulkarni; Vainav Patel; Rashmi Jalah; Candido Alicea; Steven Reed; Niranjan Sardesai; Ira Berkower; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 8.  HIV DNA Vaccine: Stepwise Improvements Make a Difference.

Authors:  Barbara K Felber; Antonio Valentin; Margherita Rosati; Cristina Bergamaschi; George N Pavlakis
Journal:  Vaccines (Basel)       Date:  2014-05-14

9.  DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques.

Authors:  Rashmi Jalah; Viraj Kulkarni; Vainav Patel; Margherita Rosati; Candido Alicea; Jenifer Bear; Lei Yu; Yongjun Guan; Xiaoying Shen; Georgia D Tomaras; Celia LaBranche; David C Montefiori; Rajasekhar Prattipati; Abraham Pinter; Julian Bess; Jeffrey D Lifson; Steven G Reed; Niranjan Y Sardesai; David J Venzon; Antonio Valentin; George N Pavlakis; Barbara K Felber
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques.

Authors:  Viraj Kulkarni; Margherita Rosati; Rashmi Jalah; Brunda Ganneru; Candido Alicea; Lei Yu; Yongjun Guan; Celia LaBranche; David C Montefiori; Alan D King; Antonio Valentin; George N Pavlakis; Barbara K Felber
Journal:  J Med Primatol       Date:  2014-05-09       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.